{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:45Z","timestamp":1792783365324,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL169578"],"award-info":[{"award-number":["R01HL169578"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL171711 and HL181226"],"award-info":[{"award-number":["R01HL171711 and HL181226"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Heart Association","award":["24CSA1255857"],"award-info":[{"award-number":["24CSA1255857"]}],"id":[{"id":"https:\/\/ror.org\/013kjyp64","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"DOI":"10.1007\/s11886-026-02420-1","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:26:49Z","timestamp":1790389609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell Type-Specific Roles for BRD4 in Heart Failure"],"prefix":"10.1007","volume":"28","author":[{"given":"Marion","family":"Delaunay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline R.","family":"Reges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preston","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Vagnozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-4470","authenticated-orcid":false,"given":"Timothy A.","family":"McKinsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"issue":"2","key":"2420_CR1","first-page":"439","volume":"32","author":"Writing Committee M","year":"2025","unstructured":"Writing Committee M. HF STATS 2025: heart failure epidemiology and outcomes statistics an updated 2025 report from the Heart Failure Society of America. J Card Fail. 2025;32(2):439\u201398.","journal-title":"J Card Fail"},{"issue":"6","key":"2420_CR2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis NG. Cardiac fibrosis. Cardiovasc Res. 2021;117(6):1450\u201388.","journal-title":"Cardiovasc Res"},{"key":"2420_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yjmcc.2014.05.002","volume":"74","author":"SM Haldar","year":"2014","unstructured":"Haldar SM, McKinsey TA. BET-ting on chromatin-based therapeutics for heart failure. J Mol Cell Cardiol. 2014;74:98\u2013102.","journal-title":"J Mol Cell Cardiol"},{"key":"2420_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-biochem-052610-095910","volume":"81","author":"Q Zhou","year":"2012","unstructured":"Zhou Q, Li T, Price DH. RNA polymerase II elongation control. Annu Rev Biochem. 2012;81:119\u201343.","journal-title":"Annu Rev Biochem"},{"issue":"34","key":"2420_CR5","doi-asserted-by":"publisher","first-page":"13690","DOI":"10.1073\/pnas.0705053104","volume":"104","author":"DA Bisgrove","year":"2007","unstructured":"Bisgrove DA, Mahmoudi T, Henklein P, Verdin E. Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proc Natl Acad Sci U S A. 2007;104(34):13690\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2420_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","volume":"19","author":"MK Jang","year":"2005","unstructured":"Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell. 2005;19(4):523\u201334.","journal-title":"Mol Cell"},{"issue":"4","key":"2420_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","volume":"19","author":"Z Yang","year":"2005","unstructured":"Yang Z, Yik JH, Chen R, He N, Jang MK, Ozato K, et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell. 2005;19(4):535\u201345.","journal-title":"Mol Cell"},{"issue":"3","key":"2420_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s44161-024-00431-1","volume":"3","author":"A Padmanabhan","year":"2024","unstructured":"Padmanabhan A, de Soysa TY, Pelonero A, Sapp V, Shah PP, Wang Q, et al. A genome-wide CRISPR screen identifies BRD4 as a regulator of cardiomyocyte differentiation. Nat Cardiovasc Res. 2024;3(3):317\u201331.","journal-title":"Nat Cardiovasc Res"},{"issue":"24","key":"2420_CR9","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1161\/CIRCULATIONAHA.120.047753","volume":"142","author":"A Padmanabhan","year":"2020","unstructured":"Padmanabhan A, Alexanian M, Linares-Saldana R, Gonzalez-Teran B, Andreoletti G, Huang Y, et al. BRD4 (bromodomain-containing protein 4) interacts with GATA4 (GATA binding protein 4) to govern mitochondrial homeostasis in adult cardiomyocytes. Circ. 2020;142(24):2338\u201355.","journal-title":"Circ"},{"issue":"24","key":"2420_CR10","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1161\/CIRCULATIONAHA.120.047239","volume":"142","author":"SY Kim","year":"2020","unstructured":"Kim SY, Zhang X, Schiattarella GG, Altamirano F, Ramos TAR, French KM, et al. Epigenetic reader BRD4 (bromodomain-containing protein 4) governs nucleus-encoded mitochondrial transcriptome to regulate cardiac function. Circ. 2020;142(24):2356\u201370.","journal-title":"Circ"},{"issue":"3","key":"2420_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","volume":"154","author":"P Anand","year":"2013","unstructured":"Anand P, Brown JD, Lin CY, Qi J, Zhang R, Artero PC, et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell. 2013;154(3):569\u201382.","journal-title":"Cell"},{"key":"2420_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138687","author":"A Antolic","year":"2020","unstructured":"Antolic A, Wakimoto H, Jiao Z, Gorham JM, DePalma SR, Lemieux ME, et al. BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.138687.","journal-title":"JCI Insight"},{"key":"2420_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah5084","author":"Q Duan","year":"2017","unstructured":"Duan Q, McMahon S, Anand P, Shah H, Thomas S, Salunga HT, et al. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aah5084.","journal-title":"Sci Transl Med"},{"key":"2420_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.yjmcc.2013.07.017","volume":"63","author":"JI Spiltoir","year":"2013","unstructured":"Spiltoir JI, Stratton MS, Cavasin MA, Demos-Davies K, Reid BG, Qi J, et al. BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. J Mol Cell Cardiol. 2013;63:175\u20139.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"2420_CR15","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.celrep.2016.06.074","volume":"16","author":"MS Stratton","year":"2016","unstructured":"Stratton MS, Lin CY, Anand P, Tatman PD, Ferguson BS, Wickers ST, et al. Signal-dependent recruitment of BRD4 to cardiomyocyte super-enhancers is suppressed by a microRNA. Cell Rep. 2016;16(5):1366\u201378.","journal-title":"Cell Rep"},{"issue":"25","key":"2420_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk8501","volume":"10","author":"R Patrick","year":"2024","unstructured":"Patrick R, Janbandhu V, Tallapragada V, Tan SSM, McKinna EE, Contreras O, et al. Integration mapping of cardiac fibroblast single-cell transcriptomes elucidates cellular principles of fibrosis in diverse pathologies. Sci Adv. 2024;10(25):eadk8501.","journal-title":"Sci Adv"},{"issue":"7","key":"2420_CR17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCRESAHA.119.315125","volume":"125","author":"MS Stratton","year":"2019","unstructured":"Stratton MS, Bagchi RA, Felisbino MB, Hirsch RA, Smith HE, Riching AS, et al. Dynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation. Circ Res. 2019;125(7):662\u201377.","journal-title":"Circ Res"},{"issue":"7867","key":"2420_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-021-03674-1","volume":"595","author":"M Alexanian","year":"2021","unstructured":"Alexanian M, Przytycki PF, Micheletti R, Padmanabhan A, Ye L, Travers JG, et al. A transcriptional switch governs fibroblast activation in heart disease. Nature. 2021;595(7867):438\u201343.","journal-title":"Nature"},{"key":"2420_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176714","volume":"977","author":"S Song","year":"2024","unstructured":"Song S, Yuan J, Fang G, Li Y, Ding S, Wang Y, et al. BRD4 as a therapeutic target for atrial fibrosis and atrial fibrillation. Eur J Pharmacol. 2024;977:176714.","journal-title":"Eur J Pharmacol"},{"key":"2420_CR20","doi-asserted-by":"crossref","unstructured":"Francois A, Bermeo-Blanco O, Nguyen BT, Marcho LM, Elbon A, Ambardekar AV, et al. Sertad4 Regulates Pathological Cardiac Remodeling. bioRxiv. 2026.","DOI":"10.64898\/2026.03.18.708586"},{"issue":"19","key":"2420_CR21","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1161\/CIRCULATIONAHA.120.046462","volume":"143","author":"JG Travers","year":"2021","unstructured":"Travers JG, Wennersten SA, Pena B, Bagchi RA, Smith HE, Hirsch RA, et al. HDAC inhibition reverses preexisting diastolic dysfunction and blocks covert extracellular matrix remodeling. Circulation. 2021;143(19):1874\u201390.","journal-title":"Circulation"},{"issue":"8","key":"2420_CR22","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.cell.2021.03.026","volume":"184","author":"RJ Mills","year":"2021","unstructured":"Mills RJ, Humphrey SJ, Fortuna PRJ, Lor M, Foster SR, Quaife-Ryan GA, et al. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection. Cell. 2021;184(8):2167-82 e22.","journal-title":"Cell"},{"issue":"2","key":"2420_CR23","doi-asserted-by":"publisher","first-page":"H294","DOI":"10.1152\/ajpheart.00438.2024","volume":"328","author":"KB Schuetze","year":"2025","unstructured":"Schuetze KB, Stratton MS, Bagchi RA, Hobby ARH, Felisbino MB, Rubino M, et al. BRD4 inhibition rewires cardiac macrophages toward a protective phenotype marked by low MHC class II expression. Am J Physiol Heart Circ Physiol. 2025;328(2):H294\u2013309.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2420_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yjmcc.2021.05.013","volume":"158","author":"I Ferrari","year":"2021","unstructured":"Ferrari I, Vagnozzi RJ. Mechanisms and strategies for a therapeutic cardiac immune response. J Mol Cell Cardiol. 2021;158:82\u20138.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"2420_CR25","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1161\/CIRCRESAHA.124.323817","volume":"134","author":"M Holt","year":"2024","unstructured":"Holt M, Lin J, Cicka M, Wong A, Epelman S, Lavine KJ. Dissecting and visualizing the functional diversity of cardiac macrophages. Circ Res. 2024;134(12):1791\u2013807.","journal-title":"Circ Res"},{"key":"2420_CR26","doi-asserted-by":"crossref","unstructured":"Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology. J Am Coll Cardiol. 2025.","DOI":"10.1016\/j.jacc.2025.08.047"},{"issue":"8038","key":"2420_CR27","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-024-08085-6","volume":"635","author":"M Alexanian","year":"2024","unstructured":"Alexanian M, Padmanabhan A, Nishino T, Travers JG, Ye L, Pelonero A, et al. Chromatin remodelling drives immune cell-fibroblast communication in heart failure. Nature. 2024;635(8038):434\u201343.","journal-title":"Nature"},{"issue":"8038","key":"2420_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-024-08008-5","volume":"635","author":"JM Amrute","year":"2024","unstructured":"Amrute JM, Luo X, Penna V, Yang S, Yamawaki T, Hayat S, et al. Targeting immune-fibroblast cell communication in heart failure. Nature. 2024;635(8038):423\u201333.","journal-title":"Nature"},{"issue":"1","key":"2420_CR29","doi-asserted-by":"publisher","first-page":"H124","DOI":"10.1152\/ajpheart.00028.2019","volume":"317","author":"RM Blanton","year":"2019","unstructured":"Blanton RM, Carrillo-Salinas FJ, Alcaide P. T-cell recruitment to the heart: friendly guests or unwelcome visitors? Am J Physiol Heart Circ Physiol. 2019;317(1):H124\u201340.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"2420_CR30","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.ajt.2025.07.2469","volume":"25","author":"X Su","year":"2025","unstructured":"Su X, Deng G, Sun S, Wang G, Hennessy-Strahs S, Li J, et al. Epigenetically modulating macrophage subpopulations to promote long-term allograft survival in a mouse heart transplant model. Am J Transplant. 2025;25(10):2067\u201381.","journal-title":"Am J Transplant"},{"issue":"10","key":"2420_CR31","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.18632\/aging.103200","volume":"12","author":"H Wang","year":"2020","unstructured":"Wang H, Fu H, Zhu R, Wu X, Ji X, Li X, et al. BRD4 contributes to LPS-induced macrophage senescence and promotes progression of atherosclerosis-associated lipid uptake. Aging (Albany NY). 2020;12(10):9240\u201359.","journal-title":"Aging (Albany NY)"},{"issue":"7794","key":"2420_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41586-020-1930-8","volume":"578","author":"EJ Faivre","year":"2020","unstructured":"Faivre EJ, McDaniel KF, Albert DH, Mantena SR, Plotnik JP, Wilcox D, et al. Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer. Nature. 2020;578(7794):306\u201310.","journal-title":"Nature"},{"issue":"5","key":"2420_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2215\/CJN.16751020","volume":"16","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Schwartz GG, Nicholls SJ, Buhr KA, Ginsberg HN, Johansson JO, et al. Effect of apabetalone on cardiovascular events in diabetes, CKD, and recent acute coronary syndrome: results from the BETonMACE randomized controlled trial. Clin J Am Soc Nephrol. 2021;16(5):705\u201316.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2420_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-020-01199-x","volume":"20","author":"SJ Nicholls","year":"2021","unstructured":"Nicholls SJ, Schwartz GG, Buhr KA, Ginsberg HN, Johansson JO, Kalantar-Zadeh K, et al. Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study. Cardiovasc Diabetol. 2021;20(1):13.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2420_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117365","volume":"45","author":"A Mengozzi","year":"2026","unstructured":"Mengozzi A, Costantino S, Mongelli A, Duranti E, Mohammed SA, Gorica E, et al. BET-induced metabolic reprogramming fuels inflammation at the vascular-fat interface in mice and patients with cardiometabolic disease. Cell Rep. 2026;45(6):117365.","journal-title":"Cell Rep"},{"issue":"22","key":"2420_CR36","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1016\/j.molcel.2024.09.030","volume":"84","author":"BN Devaiah","year":"2024","unstructured":"Devaiah BN, Singh AK, Mu J, Chen Q, Meerzaman D, Singer DS. Phosphorylation by JNK switches BRD4 functions. Mol Cell. 2024;84(22):4282-96 e7.","journal-title":"Mol Cell"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02420-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02420-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02420-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:26:52Z","timestamp":1790389612000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-026-02420-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2420"],"URL":"https:\/\/doi.org\/10.1007\/s11886-026-02420-1","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"20 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No artificial intelligence tools were used in the preparation, writing, analysis, or editing of this manuscript.","order":1,"name":"Ethics","label":"Use of Artificial Intelligence","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animal or human subjects by the authors were used in this study.","order":2,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.A.M. is a co-founder of Myracle Therapeutics and is on the scientific advisory boards of Eikonizo Therapeutics and Revier Therapeutics and is a consultant for Cardurion Pharmaceuticals and Augustine Therapeutics. The remaining authors have nothing to disclose.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"100"}}